Replies to post #353773 on Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

likely this will take market share from all adderalls. Should shrink that segment considerably

[jour_trader]

Price is one factor, efficacy is another. We know ADHD drugs, generic or brand, can have far different impacts from one person to another. Elite’s may work for some, but not for others. At the end of the day, this brings more competition to split the same pie, except Elite is on the side that can still be abused (ironic for a company that has spent millions upon millions on anti-abuse tech).

[Je3232]

Unfortunately I feel like our transformation is a bust. Here we are a year later and no news coming out of the company for some time now. Nasrat has accumulated over 270,000,000 shares I believe so he will be fine in my opinion

Me , the average shareholder, not so much as we drift down.

Again -almost 8 years later and no stock appreciation. How is this acceptable to Barry Dash and the rest of the elite board. If they can’t get it done, move aside and let someone else do it

Price Performance (52-Wk)-27.28%

[Je3232]

About a year ago, someone wrote a piece for seeking alpha. Very well written and very philosophical. Bottom line is stock has done nothing. Outside of adderall, what have these guys at elite announced that is new. We can’t even launch a product on time because the boat from India was lost

Companies grow on increased revenue and new products. Granted, they grew revenue some but then flatlined and then dropped. All of this with no explanation

Do we even have Walgreens still. Not seeing screen shots of bottles or the inventory forms being posted.

Nasrat - in my opinion as a shareholder, has failed me.